Narwhal Capital Management raised its position in Amrize Ltd (NYSE:AMRZ – Free Report) by 23.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 81,263 shares of the company’s stock after purchasing an additional 15,618 shares during the period. Narwhal Capital Management’s holdings in Amrize were worth $3,038,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of the company. Caldwell Sutter Capital Inc. boosted its stake in shares of Amrize by 11.5% in the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after buying an additional 275 shares during the last quarter. Grove Bank & Trust grew its holdings in shares of Amrize by 2.1% in the third quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock valued at $653,000 after acquiring an additional 353 shares in the last quarter. Norman Fields Gottscho Capital Management LLC increased its position in shares of Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after acquiring an additional 475 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of Amrize by 3.9% during the third quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock valued at $542,000 after acquiring an additional 543 shares during the last quarter. Finally, Choreo LLC increased its position in shares of Amrize by 4.2% during the third quarter. Choreo LLC now owns 17,713 shares of the company’s stock valued at $662,000 after acquiring an additional 706 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on AMRZ shares. Deutsche Bank Aktiengesellschaft cut their price objective on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Bank of America lowered Amrize from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $50.00 to $40.00 in a research report on Wednesday, September 2nd. JPMorgan Chase & Co. lowered their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 13th. Wells Fargo & Company lowered their target price on Amrize from $40.00 to $39.00 and set an “equal weight” rating on the stock in a research note on Friday, October 30th. Finally, UBS Group cut their price target on shares of Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a report on Tuesday, September 22nd. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Amrize has a consensus rating of “Hold” and a consensus price target of $47.65.
View Our Latest Research Report on Amrize
Insider Buying and Selling at Amrize
In other Amrize news, CEO Jan Jenisch purchased 26,000 shares of the stock in a transaction on Wednesday, September 2nd. The shares were purchased at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the acquisition, the chief executive officer directly owned 1,767,000 shares in the company, valued at approximately $75,044,490. The trade was a 1.49% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jacques Sanche bought 4,150 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was bought at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares of the company’s stock, valued at $439,665.32. This represents a 73.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders bought 34,155 shares of company stock worth $1,461,276. Insiders own 0.54% of the company’s stock.
Amrize Trading Down 2.0%
Shares of AMRZ stock opened at $41.96 on Wednesday. The stock has a market capitalization of $23.21 billion, a price-to-earnings ratio of 18.99, a PEG ratio of 1.68 and a beta of 0.04. The company’s fifty day simple moving average is $39.46 and its two-hundred day simple moving average is $50.18. Amrize Ltd has a 1 year low of $35.78 and a 1 year high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67.
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.98 EPS. As a group, analysts anticipate that Amrize Ltd will post 2.30 earnings per share for the current year.
Amrize Announces Dividend
The company also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio is presently 4.98%.
Amrize Company Profile
Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.
Further Reading
- Five stocks we like better than Amrize
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
